MYC and breast neoplasm: Here, we demonstrate in vivo that administration of a single, low dose of CpG alone was sufficient to bypass MYC-dependent repression of breast tumor cell MHC-I expression, and it increased the fraction of cytotoxic CD8 + T-cells.